Top KHN Original Stories

View More

Total Results: 15971

FDA Threatens To Prosecute Companies That Make Bogus Claims About Cancer Cures

KHN Morning Briefing

In other public health news: a “superbug” fungus is infecting hospitals in New Jersey and New York; economic inequality impacts the U.S. health care system; a link between binge drinking and abnormal heart rhythms; marijuana as a treatment for kids with autism; and more.

Maine Governor Seeks To Add Premiums And Work Requirement For Medicaid Enrollees

KHN Morning Briefing

The state government announces schedules for two hearings and a public comment period next month before submitting the request to federal regulators. Wisconsin is also hoping to institute a premium and time limit for those getting Medicaid coverage, but the proposal is drawing complaints.

Freedom Caucus Leaders Appear Ready To Support Revised GOP Health Plan

KHN Morning Briefing

Conservatives seem to be coalescing behind a health plan that includes waivers allowing states to opt out of major regulations related to essential health benefits and insurance companies to charge higher premiums for patients with preexisting conditions.

Sanofi Claims Mylan Artificially Bumped Up EpiPen Prices, Then Undercut Competition With Rebates

KHN Morning Briefing

The drugmaker filed a lawsuit against the troubled EpiPen-maker on Monday. In other pharmaceutical news, The Daily Beast investigates the involvement of Rep. Chris Collins, R-N.Y., with an Australian biotech company, a panel of U.S. scientists is questioning the methodology of an Ebola drug trial, Biogen releases the promising results of a drug to help children with a neuromuscular disease, and one California lawmaker has a plan for lowering drug prices.